Update on Biliary Cancers: the Scottish perspective

Update on Biliary Cancers: the Scottish perspective

It is our great pleasure to invite you to the “Update on Biliary Cancers: the Scottish perspective” conference taking place on 30th September 2024 at the Hilton Dunblane Hydro, Dunblane.

The management of biliary cancers has recently been transformed by the introduction of several new treatment options reflected in updated national and international guidelines. The aim of this conference is to discuss how we can implement these in Scotland in a harmonised manner, with a particular focus on new systemic treatments and molecular profiling.

We believe the conference will be of interest to all stakeholders involved in the management of patients with biliary cancer, specifically clinical nurse specialists, medical oncologists, pathologists, surgeons, and pharmacists. It will also be an excellent opportunity for trainees who want to deepen their knowledge in biliary cancers.

The event is endorsed by CCA-UK, AMMF, ENSCCA and Precision-BTC; and is supported by Astrazeneca, Servier, Incyte, Tahio and Jazz.

Chiara Braconi, Tim Kendall, Sophie McHaffie

Agenda

9:00 - 9:30 Registration

09:30-09:45 Welcome Chiara Braconi & Tim Kendall & Sophie McHaffie

CLINICAL MANAGEMENT of UNRESECTABLE BILIARY TRACT CANCERS: an UPDATE

9:45 - 10:00 Cholangiocarcinoma: the viewpoint by AMMF Helen Morement, AMMF

10:00 - 10:15 First line palliative systemic anticancer therapy : what' s the new Standard of care? Mark Baxter

10:15 - 10:30 Second line palliative systemic anticancer therapy for BTC : how to choose ?Chiara Braconi

10:30 - 10:45 Genomic Profiling in Scotland: what do we need and where are we? Tim Kendall

10:45 - 11:00 GENTLE study: feasibility of Genomic Profiling in Scotland Sophie McHaffie

11:00 - 11:15 BREAK

11:15 - 11:30 Implementation plan for genomic profiling for Scottish BTC patients Nicola Williams - SSNGM

11:30 - 11:40 Patient's perspective Margaret Sherwood

11:40 - 12:00 Government perspective(TBD)

12:00 - 12:45 PANEL DISCUSSION Mark Baxter, Alan Christie, Chris Merrick, Adnan Shaukat, Shaun Walsh, Duthie Fraser

12:45 - 13:45 LUNCH

CLINICAL MANAGEMENT OF RESECTABLE BILIARY TRACT CANCER: Open Questions

13:45 - 14:00 Anticipating diagnosis: Including BTC in the PHCCPIP for Scotland? Anya Adair / Ross Carter

14:00 - 14:15 Pre-surgical assessment: Does PET have any role? Nigel Jamieson

14:15 - 14:30 The Scottish pathway for pCCA Anya Adair

14:30 - 14:45 Adjuvant treatment: does radiotherapy have any role? Derek Grose

14:45 - 14:55Patient's perspective Benjamin Carey

14:55 - 15:30 PANEL DISCUSSION Adnan Shaukat, Euan Dickson, Rachel Guest, Nigel Jamieson, Dave Holroyd, Derek Grose, Steve Wigmore

15:30 - 15:45 BREAK

RESEARCH AT PATIENT'S SERVICE

15:45 -16:00 Biobanking: the challenges and the benefit of a coordinated programme Rachel Guest

16:00 - 16:15 The Scottish involvement in national and international consortia (CCA-UK / ENS-CCA / Precison-BTC network) Luke Boulter

16:15-16:30 CRUK Scotland Centre: integrating research and clinical care (TBD)

16:30 - 17:00 PANEL DISCUSSION

17:00 Conclusive remarks Chiara Braconi & Tim Kendall & Sophie McHaffie

Host or Publisher University of Glasgow